J 2022

Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains

RAŠKA, Filip, Břetislav LIPOVÝ, Jakub HOLOUBEK, Š. KOBZOVÁ, Lukáš VACEK et. al.

Basic information

Original name

Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains

Authors

RAŠKA, Filip (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Š. KOBZOVÁ (203 Czech Republic), Lukáš VACEK (203 Czech Republic, belonging to the institution), L. VOJTOVÁ and L. JANDA (203 Czech Republic)

Edition

Burns, OXON, ELSEVIER SCI LTD, 2022, 0305-4179

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30212 Surgery

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.700

RIV identification code

RIV/00216224:14110/22:00127028

Organization unit

Faculty of Medicine

UT WoS

000880116100012

Keywords in English

topical antimicrobial 'biobetters'; methicillin-resistant Staphylococcus aureus strains

Tags

International impact, Reviewed
Změněno: 16/1/2023 13:36, Mgr. Tereza Miškechová

Abstract

V originále

Successful control of burn wound infection is one of the keystones in the successful treatment of patients with burn injury. The increase in the prevalence of resistant strains of pathogens dramatically reduces the options of antibiotic treatment. Infectious complications caused by methicillin-resistant Staphylococcus aureus (MRSA) are known to be associated with significantly higher mortality than those caused by methicillin-sensitive strains (MSSA; 42 % and 18 %, respectively). This situation underlines the necessity for other strategies to control infectious complications of burn wounds. The use of enzybiotics (such as endolysins and lysostaphins), specific products of bacteriophages or competing bacteria, appears to be a promising alternative approach. Their advantages include high specificity and, in particular, they appear less susceptible to the development of resistant strains of bacteria. The principal limitations of the current options for the use of enzybiotics in the topical treatment of MRSA-induced burn wound infections are 1) low production associated with a high price, 2) short duration of the enzymatic activity, which is caused by the structural instability of enzymes resulting in protein denaturation and 3) low resistance of the enzyme to proteases – in particular, matrix metalloproteinases (MMPs), which are produced in the burn wound area in high amounts.